Long a lobbying powerhouse in Washington, pharma’s struggling to settle on a strategy for defending itself, according to six industry lobbyists and three company officials who spoke to POLITICO. All ...

Several major drugmakers are counting on their manufacturing flexibility to counter potential disruptions from tariffs ...

European drugmakers are urging the EU to allow higher medicine prices, warning that without stronger investment incentives, ...

Merck’s first-quarter net income increased as sales of its Keytruda cancer drug rose, but the Big Pharma company cut its 2025 ...

The pharmaceutical company said the profit was driven by a higher gross margin and slower operating expense growth.

Prospective homebuyers considering the real estate market had a range of options in various neighborhoods throughout the ...

Just as in the wake of COVID-19, the world will look to pharma to fulfil its public health needs. Yet the industry’s vulnerability to climate change means it may not be in a position to answer ...

Given widespread recognition that pharma lags behind a number of market sectors in its use digital marketing, is this debate useful or redundant? Starting with commonly used definitions ...

To strengthen its U.S. presence, Roche is building up inventory, ramping up production at three of its U.S. plants and relocating one manufacturing site to the U.S. through a technology transfer, its ...

India's drug advisory board is considering restricting over-the-counter medication sales to prevent misuse and ensure patient ...

Global Data has revealed that the Top 20 Global Biopharmaceutical Companies have witnessed a 6 % growth in market ...

Real time quote data is not available at this time. *Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green ...